ResearcherShanghai University of Traditional Chinese MedicineNo recent work listed
Zihang Xu
Matched on ORCID iD 0000-0002-1081-5559; OpenAlex author ID A5006638908. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation. Co-author DOI 10.7150/ijbs.70567↗
- Correction to: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. Co-author DOI 10.1186/s13046-020-01764-y↗
- Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. Co-author DOI 10.1186/s13046-017-0590-5↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiao Chen · 3 shared papers, 2017–2022 · strength 0.33
- Paper Alizarin, a nature compound, inhibits the growth of pancreatic cancer cells by abrogating NF-κB activation. DOI 10.7150/ijbs.70567↗
- Paper Correction to: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancr… DOI 10.1186/s13046-020-01764-y↗
- Paper Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer ce… DOI 10.1186/s13046-017-0590-5↗
- Fei Zhang · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.